The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice

European Journal of Clinical Investigation

Volumn 44, Issue 2, 2014, Pages 146-152

  Singh, Maneesh ^a   Singh, Pratibha ^a   Vaira, Dolores ^a   Torheim, Eirik A ^b   Rahmouni, Souad ^a   Taskén, Kjetil ^b,c   Moutschen, Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

cAMP; HIV; NOD LtsZ scidIL 2R null mice; RIAD peptidomimetic

Indexed keywords

ANTIGEN P24; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; PEPTIDOMIMETIC AGENT; RI ANCHORING DISRUPTOR PEPTIDOMIMETIC; UNCLASSIFIED DRUG; GAG PROTEIN; PROTEIN KINASE MODULATOR; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; NOD SCID GAMMA MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECTS; HIV INFECTIONS; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; SCID MOUSE; TRANSGENIC MOUSE; VIROLOGY;

A KINASE ANCHOR PROTEINS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; MICE, SCID; MICE, TRANSGENIC; PEPTIDOMIMETICS; SIGNAL TRANSDUCTION; VIRAL LOAD; VIRUS REPLICATION;

EID: 84892477850     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12200     Document Type: Article

References (26)

1. Hofmann B, Nishanian P, Nguyen T, Insixiengmay P, Fahey JL. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci USA 1993;90:6676-80.
2. Moreno-Fernandez ME, Rueda CM, Velilla PA, Rugeles MT, Chougnet CA. cAMP during HIV infection: friend or foe? AIDS Res Hum Retroviruses 2012;28:49-53.
3. Fimia GM, Sassone-Corsi P. Cyclic AMP signalling. J Cell Sci 2001;114:1971-2.
4. Hofmann B, Nishanian P, Nguyen T, Liu M, Fahey JL. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993;7:659-64.
5. Pidoux G, Tasken K. Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins. J Mol Endocrinol 2010;44:271-84.
6. Mosenden R, Tasken K. Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell Signal 2011;23:1009-16.
7. Aandahl EM, Aukrust P, Skalhegg BS, Muller F, Froland SS, Hansson V et al. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J 1998;12:855-62.
8. Cartier C, Hemonnot B, Gay B, Bardy M, Sanchiz C, Devaux C et al. Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J Biol Chem 2003;278:35211-9.
9. Barnitz RA, Wan F, Tripuraneni V, Bolton DL, Lenardo MJ. Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection. J Virol 2010;84:6410-24.
10. Li PL, Wang T, Buckley KA, Chenine AL, Popov S, Ruprecht RM. Phosphorylation of HIV Nef by cAMP-dependent protein kinase. Virology 2005;331:367-74.
11. Carlson CR, Lygren B, Berge T, Hoshi N, Wong W, Tasken K et al. Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem 2006;281:21535-45.
12. Mosenden R, Singh P, Cornez I, Heglind M, Ruppelt A, Moutschen M et al. Mice with disrupted type I protein kinase A anchoring in T cells resist retrovirus-induced immunodeficiency. J Immunol 2011;186:5119-30.
13. Rahmouni S, Aandahl EM, Trebak M, Boniver J, Tasken K, Moutschen M. Increased cAMP levels and protein kinase (PKA) type I activation in CD4 + T cells and B cells contribute to retrovirus-induced immunodeficiency of mice (MAIDS): a useful in vivo model for drug testing. FASEB J 2001;15:1466-8.
14. Rahmouni S, Aandahl EM, Nayjib B, Zeddou M, Giannini S, Verlaet M et al. Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem J 2004;384:469-76.
15. Torheim EA, Jarnaess E, Lygren B, Tasken K. Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling. Biochem J 2009;424:69-78.
16. Singh M, Singh P, Gaudray G, Musumeci L, Thielen C, Vaira D et al. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgamma(NULL) mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE 2012;7:e38491.
17. Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K et al. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 2008;15:1184-91.
18. Murray AJ. Pharmacological PKA inhibition: all may not be what it seems. Sci Signal 2008;1:re4.
19. Skalhegg BS, Landmark BF, Doskeland SO, Hansson V, Lea T, Jahnsen T. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3', 5'-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J Biol Chem 1992;267:15707-14.
20. Skalhegg BS, Tasken K, Hansson V, Huitfeldt HS, Jahnsen T, Lea T. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 1994;263:84-7.
21. Ruppelt A, Mosenden R, Gronholm M, Aandahl EM, Tobin D, Carlson CR et al. Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. J Immunol 2007;179:5159-68.
22. Tzitzivacos DB, Tiemessen CT, Stevens WS, Papathanasopoulos MA. Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children. AIDS Res Hum Retroviruses 2009;25:1141-8.
23. Lemay J, Maidou-Peindara P, Cancio R, Ennifar E, Coadou G, Maga G et al. AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription. J Mol Biol 2008;383:783-96.
24. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010;143:789-801.
25. Vandamme J, Castermans D, Thevelein JM. Molecular mechanisms of feedback inhibition of protein kinase A on intracellular cAMP accumulation. Cell Signal 2012;24:1610-8.
26. Pereira CF, Boven LA, Middel J, Verhoef J, Nottet HS. Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions. J Leukoc Biol 2000;68:423-8.